|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/10 | (2006.01) |
| A61K 38/10 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Patento numeris | 3459557 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17799725.1 |
| Europos patento paraiškos padavimo data | 2017-05-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/MX2017/000055 |
| Data | 2017-05-18 |
| (87) | Numeris | WO 2017/200369 |
| Data | 2017-11-23 |
| (30) | Numeris | Data | Šalis |
| 2016006460 | 2016-05-18 | MX |
| (72) |
SCIUTTO CONDE, Edda Lydia , MX
FRAGOSO GONZÁLEZ, Gladis Del Carmen , MX
TORRES GARCÍA, Diana , MX
CERVANTES TORRES, Jacquelynne Brenda , MX
SEGURA VELÁZQUEZ, René Alvaro , MX
PÉREZ TORRES, Armando , MX
MANUCHARYAN, Karen , MX
|
| (73) |
Universidad Nacional Autónoma De México ,
9° Piso de la Torre Rectoria
Ciudad Universitaria s/n, Ciudad de México 04510,
MX
|
| (54) | USE OF THE GK-1 PEPTIDE AS AN ANTITUMORAL AND/OR ANTIMETASTATIC AGENT |
| USE OF THE GK-1 PEPTIDE AS AN ANTITUMORAL AND/OR ANTIMETASTATIC AGENT |